Skip to content

Home
Blog Page
Mainboard
SME’s
IPO Size
IPO Learnings
About Us

Q-Line Biotech Limited EBITDA

Q-Line Biotech (NEW IPO) :GMP, Profit, Price & expert review

8 April 2026 by Sonu Kumar

Q-Line Biotech Limited

Q-Line Biotech Limited has filed DRHP for upcoming IPO consisting entirely as a Fresh Issue of 7,053,200 Equity Shares and no Offer for Sale.

Categories SME's, Upto 1000 Cr Tags "PURVA SHAREGISTRY (INDIA) PRIVATE LIMITED, Abhay Agrawal, Ajay Kumar Mahanty, Amita Garg, any upcoming ipos, Ayush Garg, biggest upcmoning IPOs, BSE, Dalal Street, GMP, HEM SECURITIES LIMITED, IPO, IPO Corner, IPOCorner, ipocorner.in, Listing Gain, promising upcoming ipos, Q-Line Biotech, Q-Line Biotech Limited, Q-Line Biotech Limited Cons, Q-Line Biotech Limited Core offering, Q-Line Biotech Limited Detail, Q-Line Biotech Limited DRHP, Q-Line Biotech Limited EBITDA, Q-Line Biotech Limited FAQ, Q-Line Biotech Limited Financial Data, Q-Line Biotech Limited Founding year, Q-Line Biotech Limited Fresh Issue, Q-Line Biotech Limited GMP Today, Q-Line Biotech Limited Grey Market Premium, Q-Line Biotech Limited Important Data, Q-Line Biotech Limited Important Date, Q-Line Biotech Limited IPO, Q-Line Biotech Limited IPO Allotment, Q-Line Biotech Limited Lead manager, Q-Line Biotech Limited Lot size, Q-Line Biotech Limited Managing director, Q-Line Biotech Limited Offer For sale, Q-Line Biotech Limited Official Website, Q-Line Biotech Limited PAT, Q-Line Biotech Limited Price, Q-Line Biotech Limited Promoters, Q-Line Biotech Limited Pros, Q-Line Biotech Limited Registrar, Q-Line Biotech Limited Revenue, Q-Line Biotech Limited Review, Q-Line Biotech Limited Risk, Q-Line Biotech Limited Strength, Q-Line Biotech Limited use of proceeds, Saurabh Garg, Share India Capital Services Private Limited, top ipos for 2026, top upcoming ipos, up and coming ipos, Upcoming IPO, upcoming ipos 2026 Leave a comment

© 2026 ipocorner.in • Built with GeneratePress

Search for: